Cell fate in eukaryotes is controlled by mitogen-activated protein kinases (MAPKs) that translate external cues into cellular responses. In plants, two MAPKs-MPK3 and MPK6-regulate diverse processes of development, environmental response and immunity. However, the mechanism that bridges these shared signalling components with a specific target remains unresolved. Focusing on the development of stomata-epidermal valves that are essential for gas exchange and transpirationhere, we report that the basic helix-loop-helix protein SCREAM functions as a scaffold that recruits MPK3/6 to downregulate SPEECHLESS, a transcription factor that initiates stomatal cell lineages. SCREAM directly binds to MPK3/6 through an evolutionarily conserved, yet unconventional, bipartite motif. Mutations in this motif abrogate association, phosphorylation and degradation of SCREAM, unmask hidden non-redundancies between MPK3 and MPK6, and result in uncontrolled stomatal differentiation. Structural analyses of MPK6 with a resolution of 2.75 Å showed bipartite binding of SCREAM to MPK6 that is distinct from an upstream MAPKK. Our findings elucidate, at the atomic resolution, the mechanism that directly links extrinsic signals to transcriptional reprogramming during the establishment of stomatal cell fate, and highlight a unique substratebinding mode adopted by plant MAPKs.
O rganized differentiation of functional tissue types is a critical step towards ensuring the survival and overall fitness of multicellular organisms. Fundamental to these processes are MAPK cascades-which consist of MAP3K (MAPKKK or MEKK), MAP2K (MAPKK or MEK), and MAPK-that phosphorylate and activate downstream targets to regulate cell proliferation, differentiation and polarity 1 . In plants, the MAPK cascade is known to influence development, environmental response and immunity [2] [3] [4] [5] . Among the 20 known MAPKs in Arabidopsis thaliana, MPK3 and MPK6 play a predominant role in diverse developmental programs, including embryo patterning, inflorescence architecture, floral abscission, anther and ovule development, and stomatal patterning [6] [7] [8] [9] [10] . It is therefore imperative to understand how these MAPKs recognize their target substrates and specifically activate individual developmental programs. Despite the recently reported partial crystal structure of MPK6 11 , the structural basis for its substrate association remains unclear.
The development of stomata is an excellent system for understanding how external signals are interpreted for the specification of cell fate 12, 13 . The EPIDERMAL PATTERNING FACTOR family of upstream peptide signals are secreted from stomatal precursors and detected by the ERECTA-family receptor-like kinases of their neighbouring cells. This activates the downstream MAPK cascade that is composed of YODA (YDA) MAPKKK, two redundant MAPKKs (MKK4 and MKK5) and two redundant MAPKs (MPK3 and MPK6), culminating in the prevention of stomatal differentiation by phosphorylation and inhibition of the basic helix-loop-helix (bHLH) transcription factor, SPEECHLESS (SPCH) 10, [14] [15] [16] [17] . Recent studies have shown that BREAKING OF ASYMMETRY IN THE STOMATAL LINEAGE (BASL) recruits YDA and MPK3/6 to the cortical polarity site 18 . This leads to a reduction in SPCH accumulation and eventual loss of stomatal fate in one of the two daughter cells of stomatal precursors 19 . However, unlike the mpk3 mpk6 double mutant, which produces an epidermis solely composed of stomata 10 , the basl null mutant produces a nearly normal epidermis with occasional paired stomata due to misspecification of asymmetric cell divisions 20 . Thus, the action of BASL cannot explain the mechanism by which the MAPK cascade enforces the decision to initiate stomatal differentiation.
In search of a factor that recruits MAPKs to the nucleus to downregulate SPCH, we revisited the gain-of-function mutant of SCREAM (SCRM; also known as ICE1), scrm-D, which confers constitutive stomatal differentiation 21 . SCRM and its paralogue SCRM2 function as partner bHLH proteins for SPCH as well as for the lateracting stomatal bHLH proteins, MUTE and FAMA [21] [22] [23] . The scrm-D protein has an R-to-H amino-acid substitution (R236H) within its conserved KRAAM motif 21 ; however, nothing is known about the exact function of this motif.
Here we report that the bHLH protein SCRM physically bridges MAPKs and SPCH and plays a direct role in enforcing entry into
Bipartite anchoring of SCREAM enforces stomatal initiation by coupling MAP kinases to SPEECHLESS
the stomatal lineage. A bipartite module with the unique KRAAM motif, in conjunction with an upstream conventional MAPK docking motif, mediates specific interactions with MPK3 and MPK6 in the stomata-development pathway. Precise dissection of the binding interface revealed the distinct SCRM-binding properties of MPK3 and MPK6, and further resolved cryptic functional non-redundancies between these two redundant MAPKs. The structural analysis of MPK6 at a resolution of 2.75 Å, together with ab initio modelling of the MPK6-SCRM protein-peptide complex, identified the exact amino-acid residues that serve as the binding interface. Our work provides a mechanistic basis for the function of SCRM as an integrator of upstream repressive cues and downstream activators during stomatal development, and highlights the unique recruitment mechanism of the plant MAPK signalling cascade.
Results

SCRM functions as a scaffold to recruit MAPK to SPCH.
MPK3/6-mediated phosphorylation of SPCH inhibits entry of cells into the stomatal cell lineage 10 ( Fig. 1a) . However, it remains unknown whether SPCH directly associates with MPK3 and MPK6. To address this question, we first performed yeast two-hybrid (Y2H) assays using a truncated form of SPCH without its N-terminal extension to prevent auto-activation (SPCH ΔN ) in pairwise combinations with SCRM, MPK3 and MPK6 (Fig. 1b) . No interactions were detected between SPCH ΔN and MPK3 or MPK6, whereas SPCH ΔN heterodimerizes with SCRM (Fig. 1b) . This suggests that the interaction between SPCH and MPK3/6 is either too weak or too transient to be detected, requires the SPCH N-terminal domain or that it otherwise requires a scaffolding partner.
To test these hypotheses, we designed a three-way bimolecular fluorescent complementation (BiFC) assay. First, the full-length SPCH protein was fused to the N-terminal half of yellow fluorescent protein (YFP; SPCH-YFPn) and MPK3/6 were fused to the complementary half of YFP (MPK3/6-YFPc). On coexpression of SPCH-YFPn and MPK3-YFPc or MPK6-YFPc in Nicotiana benthamiana leaves, no YFP signal was observed, indicating that SPCH does not interact directly with MPK3/6 (Fig. 1c) . A subsequent immunoblot analysis detected the accumulation of SPCH protein ( Supplementary Fig. 1 ), thus refuting the possibility that the lack of YFP signal was due to an absence of SPCH protein accumulation. SPCH forms a heterodimer with SCRM to initiate stomatal differentiation 21, 23 (Fig. 1a) . Next, we introduced non-fluorescently tagged SCRM (FLAG-SCRM driven by the CaMV35S promoter) along with SPCH-YFPn and MPK3-YFPc or MPK6-YFPc. SPCH and MPK3/6 were able to reconstitute strong YFP signals in the nuclei of N. benthamiana only in the presence of SCRM (Fig. 1c) . We thus conclude that SCRM functions as a scaffold to couple MPK3 and MPK6 with SPCH. that is yet to be demonstrated (question mark). MMC, meristemoid mother cell; P, phosphorylated. b, Y2H assays in which the DNA-binding domain alone (DB) and SPCH ΔN were used as bait, and the activation domain alone (AD), MPK3, MPK6 and SCRM were used as prey. Yeast were spotted in 10-fold serial dilutions on appropriate selection media. No interaction between MPK3 or MPK6 and SPCH was detected. The experiment was repeated independently three times with similar results. 3-AT, 3-amino-1,2,4-triazole; SD, synthetic defined. c, BiFC assays showing three-week-old N. benthamiana leaves that were agroinfiltrated using pairwise combinations of SPCH-YFPn and MPK3-YFPc, MPK6-YFPc along with 35S::FLAG-SCRM. Scale bars, 25 μm (left two columns). The right two columns are magnified images of a representative nucleus (scale bars, 10 μm). SPCH interacts with MPK3 and MPK6 in the presence, but not the absence, of SCRM. The experiment was repeated independently three times with similar results. BF, bright field.
The evolutionarily conserved SCRM KiDoK motif defines a direct MPK3/6 interaction surface. To elucidate how SCRM scaffolding of MPK3/6 and SPCH translates into organized differentiation of stomatal-lineage cells, we revisited the SCRM gain-of-function mutant, scrm-D
21
. The stomata-only epidermis in scrm-D mutants is essentially identical to that observed after the loss of MPK3 and MPK6 (mpk3 mpk6) 10 . Sequence analyses of SCRM and its orthologues revealed the presence of a putative MAPK docking site immediately upstream of the KRAAM motif, which is mutated to KHAAM in scrm-D (Fig. 2a, Supplementary Fig. 2a) . To understand the role of the conserved region that encompasses the MAPK docking and KRAAM (KiDoK) motif, we performed an unbiased Y2H screen against an Arabidopsis seedling cDNA library in which we used the KiDoK motif as bait (see Methods) . From 158 million interactions tested, only two proteins-MPK3 and MPK6-were identified with confidence scores high enough to be designated as real interactors (Supplementary Table 1 ). Further targeted Y2H assays validated the interaction of the SCRM KiDoK motif with MPK3 and MPK6, but not with a distantly related AtMAPK homologue, MPK4, that has no major role in stomatal development (Fig. 2b, Supplementary  Fig. 2b) . Notably, the scrm-D mutation in the KiDoK motif completely abolished the ability of the KiDoK motif to interact with both MPK3 and MPK6 (Fig. 2b) . Subsequently, we performed BiFC assays in N. benthamiana 24 (Fig. 2c) . Strong YFP signals were found in the nuclei of leaves coexpressing SCRM-YFPn and MPK3-YFPc or MPK6-YFPc. By contrast, no signal was detected in the pairwise combination of scrm-D-YFPn and MPK3-YFPc or MPK6-YFPc. These results indicate that the scrm-D(R236H) substitution abolishes the direct interaction with MPK3/6.
The KiDoK motif of SCRM is highly conserved among vascular and non-vascular land plants 25 ( Supplementary Fig. 2 ). To explore whether the KiDoK motif of SCRM constitutes an interaction module for MPK3/6 in diverse land plant lineages, we performed in vitro direct-binding and quantitative kinetic assays of the KiDoK motif peptide from dicots (Arabidopsis SCRM and SCRM2, and tomato (Solanum lycopersicum) ICE1), monocots (rice (Oryza sativa) ICE1 and Brachypodium distachyon SCRM) and a non-vascular plant (Physcomitrella patens PpICE) with purified AtMPK3 and AtMPK6 proteins using bio-layer interferometry 26 (BLI; Fig. 2d ,e). BdSCRM2 lacks the KiDoK motif altogether, and was therefore not used for the analyses (see Discussion). All orthologous KiDoK motif peptides showed tight binding to MPK3, with dissociation constant (K d ) values at nanomolar levels, whereas all except PpICE1 exhibited tight binding to MPK6 (Fig. 2d,e) . Again, scrm-D did not show any appreciable affinity to MPK3 or MPK6. Our results establish that the SCRM KiDoK motif is an evolutionarily conserved direct-interaction surface for MPK3/6. Functional analysis of the SCRM KiDoK motif elucidates nonredundancies of MPK3 and MPK6. To investigate the functional importance of the SCRM KiDoK motif, we performed site-directed mutagenesis of the K235 and/or R236 residues in the KRAAM motif to a non-charged residue, alanine (KRAAM was mutated to KAAAM, AAAAM, ARAAM and AHAAM), as well as deleted the docking motif from both SCRM (SCRM-ΔDocking) and scrm-D (scrm-D-ΔDocking). We then performed interaction analyses of these mutant variants with MPK3/6 using Y2H assays. Whereas the various alanine substitutions in the KRAAM motif abolished interaction with both MPK3 and MPK6, the SCRMΔDocking motif abolished interaction with only MPK6, and not with MPK3 (Fig. 3a) .
To examine the phenotypic consequence of these mutations in vivo, we introduced each mutant construct, driven by the endogenous SCRM promoter, into the Arabidopsis scrm-null-mutant. Similar to scrm-D, all alanine substitutions conferred severe stomatal clustering (Fig. 3b,c, Supplementary Fig. 3 ), emphasizing that the loss of MPK3/6 association due to the altered KRAAM motif triggers constitutive stomatal differentiation. Detailed quantitative analysis of the index of stomata + stomatal precursors (SPI; calculated as ((number of stomata + stomatal precursor cells)/number of epidermal cells) × 100) revealed that SCRM with an alanine substitution that retains the R236 residue (ARAAM) is less effective at triggering constitutive stomatal differentiation (Fig. 3c) . Similarly, SCRMpro::SCRM-ΔDocking confers a much weaker phenotype than SCRMpro::scrm-D-ΔDocking (Fig. 3b,c) . These results highlight the importance of the R236 residue in the KRAAM motif for enforcing proper stomatal development.
To further dissect the specific association of SCRM with MPK3 and MPK6, we truncated the KiDoK peptide into one containing only the KRAAM motif and a second containing only the docking motif. In vitro quantitative binding assays using BLI showed that, although the KRAAM motif binds to both MPK3 and MPK6 (K d = 2.8 ± 0.7 μM and K d = 2.4 ± 0.4 μM, respectively), the docking motif associates with only MPK6, and not with MPK3 (K d = 2.3 ± 0.5 μM and not detected, respectively; Fig. 3d) .
It is well known that MPK3 and MPK6 redundantly repress stomatal development-neither mpk3 nor mpk6 single-mutant Arabidopsis confer the stomatal clustering phenotype 10 , although they exhibit a slightly higher SPI than the wild type (Fig. 3e) . Our finding reveals a unique mode of MPK3/6 association with SCRM: MPK6 requires both the docking and the KRAAM motifs, whereas MPK3 requires only the latter (Fig. 3a,d ). If these different binding modes of MPK3 and MPK6 with SCRM reflect their in vivo ability to inhibit stomatal development, it could be used to unmask the hidden non-redundancy of MPK3 and MPK6. We first hypothesized that expression of SCRMpro::SCRM-ΔDocking in mpk3 mutant Arabidopsis-which express functional MPK6-confers exaggerated stomatal differentiation because MPK6 requires the docking motif to anchor onto SCRM. By contrast, expression of SCRMpro::SCRM-ΔDocking in mpk6 mutant Arabidopsiswhich express functional MPK3-will not enhance the phenotype of SCRMpro::SCRM-ΔDocking when expressed in the wild-type MPK3 MPK6 background because MPK3 does not seem to require the docking motif to anchor onto SCRM. To test this hypothesis, we introduced SCRMpro::SCRM-ΔDocking into the scrm scrm2 mpk3 and scrm scrm2 mpk6 triple-mutant backgrounds (Fig. 3e) . To effectively uncover subtle yet important specificity, both copies of SCRMs (SCRM and SCRM2) were eliminated. Indeed, the additional loss of mpk3 resulted in derepression of stomatal cell fate, giving rise to severe stomatal clustering, whereas the additional loss of mpk6 showed no discernible phenotypic enhancement (Fig. 3e,f) . These striking phenotypic differences between mpk3 and mpk6 seedlings expressing SCRM-ΔDocking in the scrm scrm2 background emphasize the notion that MPK3 and MPK6 feature a major difference in their binding modes (common-docking (CD) domain, see below) that are responsible for recognizing the conventional MAPK docking motif within the SCRM KiDoK sequence. Thus, by detaching the docking and KRAAM motifs, we can reveal cryptic functional non-redundancies between MPK3 and MPK6 in repressing stomatal cell fate.
Structural analyses of the SCRM KiDoK-MAPK interaction module. The KRAAM motif is unique to SCRM orthologues and has otherwise not been found to be involved in binding MAPK in plants or animals. To gain structural insight into its function, we first independently determined the crystal structure of MPK6 (residues 32-395, MPK6ΔNt) at a resolution of 2.75 Å (Supplementary Figs. 4a and 6 ; see Methods). MPK6 crystallized with two molecules in the asymmetric unit and displayed packing and main chain alignment that closely resembled the partial structure previously determined at a resolution of 3.2 Å 11 ( Supplementary Figs. 4a  and 6 ). MPK6 forms a bilobed structure divided between the N and 
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At scrm-D C terminus, with an ATP-binding pocket between the two lobes. Secondary structure components of our MPK6 structure are given the following labelling scheme: α−helices H1-H20 and β-strands S1-S10 (Supplementary Figs. 4a and 6). Mammalian MAPKs possess a docking groove in the C-terminal lobe that contains a highly conserved CD domain mostly composed of negatively charged residues that bind to activators (MAPKKs and MEKs), inactivators (MKPs) and substrates 27 . In most MAPKs, these exposed, negatively charged residues (aspartic acid or glutamic acid) are involved in mediating peptide-substrate binding 28 .
We found that the CD domain is mostly conserved between the MPK3/6 and mammalian ERK/p38 family ( Supplementary Fig. 7 ). In fact, the structure of AtMPK6 reveals the highly conserved D353 and D356 residues exposed from H18 within the CD domain ( Supplementary Fig. 4) .
To probe the possible role of the CD domain of MPK6 in SCRM binding, we performed Y2H assays with CD domain mutations (D353N and D356N (MPK6-CD DtoN )) that disrupt the two conserved aspartic acid residues. MPK6-CD DtoN was unable to associate with both SCRM and scrm-D KiDoK motif (Fig. 4a) , indicating that MPK6 binds to SCRM via its conserved CD domain, possibly using a mechanism similar to that in mammalian MAPKs. These results were further supported by in vitro BLI measurements, which showed that MPK6-CD DtoN failed to show appreciable affinity towards SCRM KiDoK (K d value: not fittable) compared with the wild-type MPK6 protein (K d = 47 ± 6 nM; Fig. 4b ). Taken together, the structure-function analyses of MPK6 and the SCRM KiDoK motif reveal a conserved mechanism of substrate binding between The contact residues are shown in blue on MPK6 and red on the SCRM KiDoK peptide. The non-terminal missing regions of the MPK6 structure (chain B) were modelled using Modeller and the resulting structure was used as an input for the Rosetta FlexPepDock program along with the 35-residue sequence of the SCRM KiDoK peptide. d, Magnification of R213 (red) of SCRM (orange) and D353 and D356 (blue) of MPK6 (cyan). Oxygen is shown in red and nitrogen is shown in blue. e, Magnification of K215 (red) of SCRM (orange) and E120 (blue) of the CD motif of MPK6 (cyan). f, Magnification of R236 (red) of SCRM (orange) and D148 (blue) of MPK6 (cyan). For d-f, polar contacts are represented by yellow dotted lines. g, Y2H assays in which SCRM KiDoK motif and MKK5 were used as bait and the AD alone, MPK6, MPK6(D148N) and MPK6(E120N) were used as prey. Yeast were spotted in 10-fold serial dilutions on appropriate selection media. Although the D148N and the E120N mutation in MPK6 substantially reduces the interaction between SCRM KiDoK and MPK6, the mutation does not alter the interaction with other MPK6 substrates, such as MKK5. The experiment was repeated independently three times with similar results. h, Residue swap Y2H assays in which the DNA-binding domain alone (DB), the SCRM KiDoK motif and the SCRM KiDoK(R236D) motif were used as bait. MPK6 and MPK6(D148R) were used as prey. Swapping the residues of the D148 and R236 contact sites of MPK6 and SCRM maintained interaction between the mutant variants of MPK6 and the SCRM KiDoK motif, albeit to a lesser extent compared with their wild-type counterparts. The experiment was repeated independently three times with similar results. i, Quantitative analyses of the interactions between the SCRM KiDoK motif and GST-MPK6, GST-MPK6(D148N) and GST-MPK6(E120N) using BLI. In vitro binding response curves for GST-MPK6, GST-MPK6(D148N) and GST-MPK6(E120N) with SCRM KiDoK peptide at six different concentrations (150 nM, 75 nM, 37.5 nM, 18.75 nM, 9.375 nM and 4.6875 nM) are shown. The D148N and E120N mutations in MPK6 substantially reduce the binding responses as well as the K d values for their interactions with the SCRM peptide. K d values are indicated on the plot. j, Surface conservation mapping of MPK6 (cyan-maroon) with the SCRM peptide (orange). Surface colouring reflects sequence conservation between A. thaliana MPK6 and H. sapiens ERK1, ERK2, ERK5, p38α, p38β, p38γ and p38δ. Maroon patches represent more conserved regions and cyan patches represent less conserved regions. MPK6 residues that bind to the SCRM docking motif (that is, E120, D353 and D356) are substantially more conserved than the D148 contact site-which specifically binds to the SCRM-KRAAM motif-indicating substrate specificity in MAPKs with respect to the functional outcomes that they control. For b and i, data are mean ± s.d., representative of three independent experiments. ND, not detectable. plant and animal MAPKs through the CD domain and the docking motif of their diverse substrates. However, the results do not address how the KRAAM motif-which is shared only among SCRM orthologues-governs specific binding to MPK3/6.
Deciphering the MPK6-SCRM binding interface. To understand the structural basis of how the single-residue substitution within the SCRM-KRAAM motif abolishes the association with MAPKs, we initially sought to resolve the crystal structure of MPK6-SCRM KiDoK complex, which was unfortunately recalcitrant to crystallization. As an alternative approach, we resorted to ab initio modelling of the MPK6-SCRM protein-peptide complex and performed docking simulations of SCRM KiDoK peptide onto our AtMPK6 crystal structure (Protein Data Bank (PDB) 6DTL; Fig. 4c-f) . Linear binding motifs that interact with the kinases are often devoid of tertiary structure and form a well-defined structure only in the presence of its binding partner 29 . In light of this, flexible docking was performed whereby the SCRM KiDoK peptide was allowed to fold near the CD domain and docking groove with multiple constraints imposed using information from previous studies 11, 28, 29 as well as experiments defined in this study (see Methods). The SCRM docking motif was restrained to the D-motif binding site-which comprises the CD domain and the hydrophobic docking groove 11 -and the KRAAM motif was restrained to be in the vicinity of the MPK6 structure. The R213 residue of the SCRM docking motif was restrained to remain near the negatively charged CD domain residues D353 and D356 (Fig. 4d) . A comparison of previously determined ERK2-substrate peptide complexes (ERK2-pepMNK1, PDB 2Y9Q and ERK2-pepRSK1, PDB 3TEI) 28 with our MPK6 crystal structure indicated a possible interaction between the positively charged residue K215 of the SCRM docking motif and E120 of MPK6 (Fig. 4e) . Here the resolved structures of human ERK2-pepMNK1 and ERK2-pepRSK1 complexes show that ERK2 E81 and the homologous MPK6 E120 come in direct contact with R447 and R725 of pepMNK1 and pepRSK1, respectively ( Supplementary Fig. 5 ).
Next, we performed functional analyses to validate the two topscoring final models. One model predicted amino acids E163 and E164 of MPK6 as possible sites that interact with R236 of SCRM. This was rejected by the experimental validation because sitedirected mutations within these MPK residues to eliminate negative charges (E163N and E164N) showed no effects on SCRM interaction ( Supplementary Fig. 7 ). The other model predicted amino acid D148 of MPK6 as a potential interaction partner of the R236 residue within the KRAAM motif, which was fully supported by further experimental verifications (see below).
Bipartite recruitment of MPK6 by SCRM using a conventional docking site and a SCRM-specific motif. The MPK6-SCRM interaction model predicted the bipartite binding mode of SCRM to MPK6-the docking motif that associates with the CD domain of MPK6, the KRAAM motif that lies at the neck of MPK6 N-and C-terminal lobes with MPK6 D148 as a site that interacts directly with SCRM R236, the key residue within the KRAAM motif (R236 is mutated to H in scrm-D; Fig. 4) . Importantly, the MPK6 D148 site is not conserved among mammalian MAPKs ( Supplementary  Fig. 7b ). To investigate the importance of MPK6 D148 and SCRM R236 as a binding interface, we first performed site-directed mutagenesis. The D148N substitution in MPK6 compromised its interaction with the SCRM KiDoK motif substantially in Y2H and in vitro quantitative binding kinetics assays that used BLI (Fig. 4g,i,  Supplementary Fig. 7a ), indicating that the MPK6 D148 is indeed critical for binding with SCRM through the R236 residue within the KRAAM motif.
Next, to address whether the polar interactions between MPK6 D148 and SCRM R236 is sufficient for MPK6-SCRM association, we swapped these residues to D148R and R236D, respectively. As shown in Fig. 4h , MPK6(D148R) and SCRM(R236D) were able to maintain interaction, albeit to a lesser extent than their wild-type counterparts. This suggests that MPK6 D148 and SCRM R236 serve as a critical interaction interface even when they are placed out of context from their native protein environments.
To gain further insight into the bipartite binding mode, we performed surface conservation mapping of the AtMPK6-SCRM complex and H. sapiens ERK1, ERK2, ERK5, p38α, p38β, p38γ and p38δ. Whereas AtMPK6 residues that bind the SCRM docking motif (that is, D353, D356 and E120) are highly conserved in mammalian MAPKs, the D148 contact site is far less conserved, thus reflecting the uniqueness of the binding of the SCRM-KRAAM motif to MPK6 (Fig. 4g,h,j) . Finally, to decipher the specific role of MPK6 D148 during association with SCRM-KRAAM motif, we examined whether the MPK6(D148N) substitution-which disrupts association with SCRM-has any effects on the ability of MPK6 to recruit the upstream MAPKK, MKK5 30 . Indeed, MPK6(D148N) retained interaction with MKK5 at a similar level to wild-type MPK6 (Fig. 4g) . MPK6 with an additional substitution of E120N also retained the ability to associate with MKK5 but showed compromised binding to SCRM KiDoK (Fig. 4g,j) , further emphasizing the intricate nature of MPK6-SCRM binding. Taken together, our structural and ab initio modelling of the MPK6-SCRM KiDoK complex and further experimental verifications elucidate a unique, bipartite binding mode of SCRM with MPK6-one that uses both conserved substrate binding sites that are similar to animal MAPKs, and contact sites that are highly unique to SCRM, the combination of which results in the specialized direction of cell fate during stomata development.
Binding of SCRM KiDoK and MPK3/6 is critical for SCRM phosphorylation and stability. To examine whether MPK3/6 can modify SCRM but leave scrm-D unaffected, we first performed an in vitro kinase assay using purified, recombinant constitutively active MAPKK (MKK5 DD ), MPK3, MPK6, SCRM and scrm-D (see Methods). In the presence of MPK3 and MPK6 that is activated by MKK5 DD , we detected strong phosphorylation of glutathione S-transferase (GST)-tagged SCRM as previously reported in the context of freezing tolerance 31, 32 . By contrast, GSTscrm-D was not phosphorylated by either MPK3 or MPK6 (Fig. 5a) .
To study the in vivo consequences of the MPK3/6-mediated SCRM phosphorylation, we first generated double transgenic Arabidopsis seedlings that expressed a functional, epitope-tagged SCRM as well as scrm-D driven by the endogenous promoter (SCRMpro::FLAG-SCRM and SCRMpro::FLAG-scrm-D) and an inducible constitutively active MAPKK, DEX::FLAG-NtMEK2 DD , which has been widely used to activate Arabidopsis MPK3/6 in vivo 10, 33 (Fig. 5b) . On dexamethasone (DEX) induction, the SCRM protein readily degrades, whereas after treatment with the proteasome inhibitor MG132 in the presence of DEX induction, the protein accumulation level of FLAG-SCRM is restored in the SCRMpro::FLAG-SCRM seedlings (Fig. 5b) , indicating that SCRM is subjected to proteasome-mediated degradation following induction of MAPK-mediated phosphorylation. By contrast, the scrm-D protein remained stable regardless of the NtMEK2 DD induction or treatment with a proteasome inhibitor (Fig. 5b) .
Next, we examined the in vivo stability of SCRM and scrm-D proteins during seedling epidermal development using double transgenic seedlings that expressed functional green fluorescent protein (GFP)-fused SCRM and scrm-D along with DEX::FLAGNtMEK2 DD (Fig. 5c ). Whereas NtMEK2 DD induction triggered loss of GFP signals from the epidermis of SCRMpro::GFP-SCRM 24 h after treatment with DEX (Fig. 5c,d) , the GFP signals from SCRMpro::GFP-scrm-D seedlings persist even 24 h after the activation of MAPKs in vivo (Fig. 5c,d) . We further examined the in vivo stability of the SPCH-GFP protein-a heterodimeric partner of SCRM that is also targeted by MPK3/6 17, 23 following induction of NtMEK2 DD . Similar to SCRMpro::GFP-SCRM, SPCHpro::SPCH-GFP signals diminished by 6 h and were lost by 24 h after DEX treatment (Fig. 5c,d ). On the basis of these results, we conclude that the direct association of SCRM and MPK3/6 through the KiDoK motif is critical for subsequent phosphorylation and degradation of SCRM as well as SPCH, thereby specifying proper cell fate during stomatal differentiation (Fig. 6 ).
Discussion
Our study elucidates-at the atomic resolution-the mechanism by which SCRM integrates upstream MAPK cascade repressors and the downstream transcription factor SPCH to enforce the initiation of stomatal cell lineages on the developing plant epidermis (Fig. 6 ). Both the kinase docking and KRAAM motifs of SCRM are necessary for MPK6 binding, whereas the former motif seems to be dispensable for association with MPK3 (Fig. 3) . The sequence conservation of the SCRM KiDoK motif among SCRM orthologues ( Supplementary Fig. 2a ) suggests their nuanced regulation by MAPKs. The high sequence conservation of the KRAAM motif within the SCRM proteins from both vascular and non-vascular plants correlates with their tight binding to AtMPK3, whereas the relatively low sequence conservation of the kinase docking motif correlates with their disparate binding to AtMPK6 (Fig. 2d,e) . This is most evident in P. patens SCRM (PpICE1), which has a highly conserved KRAAM (KRAAS) motif but a poorly conserved kinase docking motif-PpICE1 associates strongly with AtMPK3 but very poorly with AtMPK6. These findings imply an elaboration of a bipartite binding mode of SCRM with MAPKs during the evolution and diversification of land plants. The cryptic functional non-redundancies between MPK3 and MPK6, unravelled through mutational analysis of the KiDoK motif (Fig. 3e,f) , further hint at the hidden, unique properties associated with these two MAPKs. Among the SCRM orthologues, BdSCRM2 lacks the entire KiDoK region altogether, yet it can substitute for BdICE1 to produce normal stomata in Brachypodium 34 . As expected from the amino-acid sequence, BdSCRM2 does not interact with AtMPK3/6 ( Supplementary  Fig. 2c ), suggesting that BdSCRM2 is not under direct regulation by the MAPK cascade. Therefore, grass species may have not only rewired the core stomatal bHLH transcription factors 34 , but also reshaped the architecture of the repressive signalling pathway feeding into the stomatal differentiation program.
The inability of the scrm-D protein to associate with MPK3/6 prevents its phosphorylation and subsequent degradation (Figs. 5 and 6). Thus, the KiDoK motif of SCRM essentially functions as a degron, controlling the stability of the SCRM protein. Over the years, a number of components that facilitate the degradation of SCRM in diverse biological contexts have been identified. For example, during freezing acclimation, the E3 ligases HOS1 and SIZ1 mediate the ubiquitination and SUMOylation of SCRM/ICE1 and its subsequent degradation 35, 36 . Furthermore, the OST1 kinase enhances SCRM/ICE1 stability by suppressing HOS1-mediated degradation of SCRM in the cold 37 . Recently, another E3 ligase, COP1, has been shown to suppress stomatal development in the dark by ubiquitinating and degrading SCRM 38 . This COP1-mediated SCRM degradation can be abrogated by light. As such, identification of E3 ligase that regulates the SPCH-SCRM bHLH heterodimer module during normal stomatal development is an important future direction.
SCRM controls developmental and environmental processes outside of stomatal differentiation, likely by associating with specialized bHLHs 39, 40 . For example, SCRM forms a heterodimer with ZHOUPI, a specialized bHLH protein involved in endo sperm and seed development 41 . Therefore, our discovery that SCRM acts as a scaffold to recruit MPK3/6 to its partner bHLH, SPCH, could be a universal mechanism for MPK3/6-mediated regulation of transcriptional reprogramming in diverse contexts. Recent studies have shown that phosphorylation of SCRM by MPK3/6 is critical for acclimatization of plants to freezing conditions 31, 32 . It is unknown whether SCRM forms heterodimers with specialized bHLHs and regulates their phosphorylation as a scaffold for the cold-tolerance pathway.
The proposed bipartite binding mode of the SCRM KiDoK motif interaction with MPK6 explains the complexity of binding specificity between MPK3/6 and SCRM. Although mammalian MAPKs are known to interact with their substrates using a conserved kinase interaction motif [KR]X [2] [3] [4] [5] [6] [LI]X[LI] 42 , this type of motif has been identified in plants only in APC21, an Arabidopsis type 2C Ser/Thr phosphatase that negatively regulates MPK4 and MPK6 and modulates innate immunity, jasmonic acid and ethylene levels 43 . It seems rather unlikely that diverse MAPK substrates use similar kinase interaction motifs to interact with MAPKs that are known to simultaneously influence a variety of developmental programs.
Our quantitative binding assays using BLI revealed that individual docking and KRAAM peptides exhibit lower affinity (K d values in the micromolar range) to MPK6, whereas the longer KiDoK Figs. 2e and 3d). This is probably due to cooperative binding of these two motifs to MPK6. Interestingly, MPK3 exhibits weak binding to the KRAAM peptide but no binding to the docking peptide (Fig. 3d) . However, the KiDoK peptide associates with MPK3 just as tightly as MPK6 (Fig. 2d,e) . These findings suggest that, although the docking motif per se is not sufficient for binding to MPK3 with an affinity detectable by BLI, it might help the KRAAM motif to bind more tightly to MPK3 and vice versa. Future structural analysis of the MPK3-KiDoK peptide complex will help elucidate the interface and the underlying mechanism. The highly conserved KRAAM motif is found only in SCRM and SCRM2 and its plant orthologues, reiterating the notion that distinct binding motifs in MAPK substrates are used to elicit unique developmental responses. Furthermore, it is also known that putative kinase interaction motifs in MAPK substrates rarely overlap with other highly conserved domains (for example, the bHLH domain), indicating that diverse MAPK substrates might not compete for the same binding site on MAPKs to specify a unique developmental outcome 1 . Our structural and functional analyses of the MPK6-SCRM KiDoK complex indicate that the simultaneous association of the docking and the KRAAM motifs of SCRM with MPK6 is required to dictate cell fate specification during stomatal development. Whereas it is evident from the surface conservation mapping of AtMPK6 and mammalian MAPK orthologues that the D148 residue of AtMPK6 is not as conserved with mammalian MAPK orthologues (Fig. 4j) , it is perfectly conserved among Arabidopsis MAPKs (Supplementary Fig. 7d ). Conversely, a sequence conservation analysis among CD domain residues of all AtMAPK family members revealed the contact sites to be highly diverse (Supplementary Fig. 7e ). These findings explain why the bipartite binding mode is required for SCRM to uniquely interact with MPK6-but not with other MPKs such as MPK4 (Supplementary Fig. 2b )-to specify cell fate during stomatal development.
The scaffolding action of SCRM, as discovered through our structural and functional analyses, has shed light on its post-translational regulation during stomata development. Although wild-type SCRM enables MAPK to interact with SPCH and, consequently, regulate its activity through phosphorylation, scrm-D can no longer serve as a scaffold to facilitate this interaction owing to its R236H substitution, which abolishes interaction with D148 of MPK6 (Fig. 6) . A direct ramification is the enhanced stability of SPCH in the scrm-D background, conferring constitutive stomatal differentiation (Fig. 6) .
It has been shown that BASL acts as a scaffold protein by directly binding to YDA, and localizes MPK3/6 activity to the cellular cortex within the stomatal lineage cells 18, 19 . While this manuscript was under review, another stomatal-lineage polarity protein-POLAR 44 -was reported to function as a scaffold to recruit GSK3-BIN2 that suppresses the MAPK cascade so that SPCH levels remain high in the meristemoid mother cells to promote division 45 . Collectively accounting for these discoveries, we propose that multiple actions of different scaffold proteins converge onto the regulation of SPCH activity and accumulation at specific developmental stages-SCRM acting during the initial decision process, POLAR promoting asymmetric division and BASL differentiating the fate of two daughter cells. By serving as a direct scaffolding partner for SPCH and MPK3/6, SCRM bridges the gap in our understanding of how multiple opposing signalling cues get integrated simultaneously into the highly regulated stomatal differentiation pathway to seamlessly deliver systematic cell-state transitions during plant development.
Methods
Plant materials and growth conditions. All Arabidopsis plants used in this study are from the Columbia (Col-0) background. scrm, scrm2, scrm-D, SCRMpro::GFP-SCRM, SCRMpro::GFP-scrm-D, mpk3, mpk6 and MEK2DD have been reported previously 10, 21 . Transgenic plants expressing the SCRM-KRAAM motif substitutions (SCRMpro::SCRM-KAAAM, SCRMpro::SCRM-ARAAM, SCRMpro::SCRM-AHAAM, SCRMpro::SCRM-AAAAM) as well as the SCRM docking motif deletions (SCRMpro::FLAG-SCRM-ΔDocking and SCRMpro::FLAGscrm-D-ΔDocking) in scrm and scrm scrm2 backgrounds were generated in this study. Plants were grown at 21 °C with a long-day light cycle (16 h light and 8 h dark). The primers used for genotyping and construct generation are listed in Supplementary Table 3 .
Plasmid construction and generation of transgenic plants. For the complete list of plasmids generated in this study, see Supplementary Table 3 . To generate the MPK6 ΔN terminus for recombinant protein expression, the coding sequence of MPK6 (85-1188 bp) was amplified using Phusion polymerase and cloned into pGEX-4T-1 using the BamHI and NotI restriction sites. For Y2H assays, the coding sequence of the gene of interest was fused to either the DNA-binding domain of the pGBKT7 vector or the activation domain of the pGADT7 vector using restriction sites EcoR1 and BamHI. For site-directed mutagenesis, complementary primers with corresponding mutation sites were designed for PCR amplification of the template plasmid using PrimeStar polymerase. The PCR products were then treated with DpnI to digest the parental methylated DNA. The digested PCR products were purified using a Qiagen PCR purification kit and transformed into DH5α chemically competent cells. The mutated transformants were confirmed by sequencing. For BiFC assays, split YFP constructs were generated by cloning the gene of interest into either the 35S::pSPYNE-GW vector 24 , which contains the N-terminal of EYFP (YFPn, 174 amino acids) or 35S::pSPYCE-GW, which contains the C-terminal of EYFP (YFPc, 64 amino acids), using the LR Gateway recombination cloning methods 24 . The constructs were then transformed into the Agrobacterium strain GV3101 and coinfiltrated along with the silencing suppressor plasmid p19 into N. benthamiana leaves. To generating transgenic plants, constructs were transformed into the Agrobacterium strain GV3101, and transgenic plants were subsequently generated using the floral dipping method 46 . The alanine substitution constructs were transformed into a null allele of SCRM (scrm; also known as ice1-2). The SCRMpro::FLAG-SCRM-ΔDocking and SCRMpro::FLAG-scrm-D-ΔDocking constructs were transformed into the scrm scrm2 double mutant background to uncover a subtle phenotypic difference that might be masked by the presence of functional SCRM2 alleles. For this study, we isolated the following numbers of T1 lines (after confirming the phenotypes by confocal microscopy): Y2H screen. Y2H screening was performed by Hybrigenics Services (http://www. hybrigenics-services.com). The coding sequences for A. thaliana SCRM (encoding amino acids 207-297, NM_113586.4) were PCR-amplified and cloned into pB27 as a C-terminal fusion to LexA (orientation LexA-bait). The construct was checked by sequencing the entire insert and used as a bait to screen a random-primed cDNA library in A. thaliana one-week-old-seedlings that was constructed into pP6. pB27 and pP6 were derived from the original pBTM116 47 and pGADGH 48 plasmids, respectively. We screened 158 million interactions using a mating approach with YHGX13 (Y187 ade2-101::loxP-kanMX-loxP, MATα) and L40 Gal4 (MATa) yeast strains as previously described 49 . Fifty positive clones were selected on a medium lacking tryptophan, leucine and histidine. The prey fragments of the positive clones were amplified by PCR and sequenced at their 5′ and 3′ junctions. The resulting sequences were used to identify the corresponding interacting proteins in the GenBank database (NCBI) using a fully automated procedure. A confidence score (predicted biological score) was attributed to each interaction as previously described 50 ; see Supplementary Table 1 for the full list.
Y2H assay. Bait and prey constructs were cotransformed into the yeast strain AH109 using the yeast transformation kit (Frozen-EZ Yeast Transformation II Kit, Zymo Research). Y2H assays were performed using the Matchmaker 3 Two-Hybrid system (Clontech). The resulting transformants with appropriate positive and negative controls were spotted on SD (−Leu, −Trp) plates to check for growth in the absence of selection. The transformants were then spotted on SD (−Trp, −Leu, −His) selection media containing 1 mM 3-amino-1,2,4-triazole (Sigma, A8056). The positive interactors were then scored on the basis of the stringency of the selection.
BiFC assay. BiFC assays were carried out as previously described 24 with minor modifications. Split YFP constructs were generated for SCRM, scrm-D, MPK3, MPK6 and SPCH by cloning them into either the 35S::pSPYNE or the 35S::pSPYCE Gateway recombination vector 24 . The constructs were then transformed into the Agrobacterium tumefaciens strain GV3101. Luria-Bertani (LB; 3 ml) medium was inoculated with the Agrobacterium transformants and incubated overnight with gentle shaking at 28 °C. The next morning, cultures were spun down at 4,500 r.p.m. for 10 min and resuspended in infiltration buffer (10 mM MgCl 2 , 10 mM MES (pH 5.6) and 150 μM acetosyringone). Bacterial culture densities were adjusted to a final optical density at 600 nm (OD 600 ) of 1.0, and the cell suspensions were incubated at room temperature for 4 h before infiltration. Equal volumes of cultures carrying the corresponding complementary pair of BiFC constructs (YFPn and YFPc) along with a silencing suppressor plasmid-p19 (a gift from D. Baulcombe)-were then coinfiltrated into 3-4-weekold N. benthamiana leaves. The infiltrated leaves were imaged using confocal microscopy two days after infiltration.
Confocal microscopy. Confocal imaging of Arabidopsis seedlings was performed using a Zeiss LSM700 confocal microscope. Cell peripheries were visualized by staining with propidium iodide (Molecular Probes) and imaged by using the following settings: excitation 515 nm, emission 623-642 nm. Confocal imaging for N.Benthamiana leaves was performed using a Leica SP5x confocal microscope simultaneously capturing YFP (using the white-light laser; excitation at 518 nm and emission at 540 nm for EYFP) and bright-field channels. The confocal images were linearly adjusted uniformly for brightness and contrast using Photoshop CS6 (Adobe).
Quantitative analysis and statistics. Quantitative analyses of SPCH-GFP, SCRM-GFP and scrm-D-GFP signal intensities were performed using Imaris v.8.1.3 as previously described 51 . Specifically, serial z-stack confocal images covering the entire nuclei were subjected to surface rendering in the green channel to capture SPCHpro::SPCH-GFP-, SCRMpro::GFP-SCRM-and SCRMpro::GFPscrmD-expressing nuclei in the three-dimensional space (for each time point). A cut-off value of 0.7 was set for sphericity, which effectively removed objects with non-specific signals. To ensure unbiased, highly stringent analysis of the GFP intensities, signals were restricted such that only those that originated from stomatal precursor cells were used for the analysis, and any GFP signals of SCRM-GFP and scrm-D-GFP detected from mature guard cells that had essentially formed by bypassing the effect of NtMEK2 DD treatment were eliminated from the analyses. The GFP signal intensity sum and s.d. for each nucleus was subsequently calculated. Graphs were generated using R ggplot2 as previously described 51 . All statistical analyses were performed using R v.3.3.1. See Supplementary Table 5 for exact P values for statistical analysis.
Proteasome inhibitor treatment. Arabidopsis seedlings carrying DEXinducible NtMEK2
DD (DEX::FLAG-NtMEK2 DD ) with SCRMpro::GFP-SCRM and SCRMpro::GFP-scrm-D were grown in sterile Petri dishes containing water for 4 d, after which 50 μM MG132 (or an equal volume of ethanol for the mock control) and/or 0.5 μM DEX (or an equal volume of ethanol for the mock control) were added and incubated for 6 h. The tissue was then collected and flash-frozen in liquid nitrogen. Total protein was extracted using extraction buffer containing 50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS, 100 μM phenylmethyl sulfonyl fluoride (PMSF) and 1:100 protease inhibitor cocktail. Total protein (30 μg) was loaded onto an 8% SDS-PAGE gel, after which the proteins were transferred from gel to membrane and probed using an anti-FLAG antibody (Sigma).
Recombinant protein expression and purification.
A. thaliana MPK6 encompassing residues 29-305 (MPK6ΔNt) was cloned and expressed in Escherichia coli with an N-terminal GST tag and a thrombin cleavage sequence. Initial purification from cell lysate was performed using a glutathione agarose column. After loading and washing the column, the GST tag was removed using an on-column thrombin cleavage reaction to elute MPK6ΔNt. Further purification was performed using anion-exchange and gel-filtration columns. The final protein elution buffer consisted of 20 mM Tris pH 8.0, 200 mM NaCl and 5 mM dithiothreitol (DTT).
Crystallization conditions and data collection. MPK6ΔNt crystals were grown at 4 °C using hanging-drop vapour diffusion. Protein (1.5 μl) was mixed with 1.5 μl mother liquor (0.1 M sodium citrate pH 6.5, 16% PEG 8000) and suspended from a glass slide. Crystals were collected, incubated in 25% glycerol as a cryoprotectant and flash-frozen in liquid nitrogen. Diffraction data were collected remotely at the wavelength of 1 Å from the Advanced Light Source at Lawrence Berkeley National Laboratory on the BL8.2.1 beamline; diffraction data were indexed, integrated and scaled with HKL-2000 (ref. 52 ).
Crystal structure determination and refinement. The MPK6ΔNt structure was solved by molecular replacement using the Phaser-MR program v.2.1 53 in the Phenix software suite v.1.10.1-2155 and PDB 5CI6 as a search model. An initial MPK6ΔNt structure was created with AutoBuild and subsequently refined over successive cycles with Coot v.0.8.6.1 (ref. 54 ) and phenix.refine 55 . All structure figures were created using PyMOL v.2.2.0 (https://pymol.org/). See Supplementary Table 2 for statistics from crystalic analysis.
Modelling and docking of SCRM peptide to MPK6 crystal structure. The nonterminal missing regions of the MPK6 structure (chain B) were modelled using Modeller v.9.17 (ref. 56 ). The modelled MPK6 structure was used as an input for Rosetta flexpepdock 57 along with the 35-residue-long amino-acid sequence of the SCRM peptide for ab initio flexible docking. The initial structure of peptide sequence was modelled using the ab initio modelling protocol of Rosetta software suite v.3 (refs. 58, 59 ). For the initial docking model, constraints were imposed to keep the Cα atoms of the SCRM amino acids R213 and K215 within 10 Å of Cα atoms of the MPK6 CD domain conserved residues D353 and D356. Furthermore, residues L217, K218, E221 and L223 of SCRM were constrained to be within 10 Å of the Cα atoms of the residues Y168, N200, H165, L197, I154 and L161 of MPK6. These constraints were determined from previous studies on MAPK-peptide interactions 11, 28, 29 . Finally, the Cα atoms of the SCRM-KRAAM motif (residues 235-239) were restrained to remain within 10 Å of the MPK6 molecule. For the final models, side chain constraints were used to restrain the SCRM residue R213 near MPK6 residues D353 and D356. The side chain of SCRM residue K215 was restrained to interact with amino acid E120 of MPK6. Additionally, the side chain of SCRM residue R236 was restrained to interact with amino acid D148 of MPK6. The rest of the constraints were similar to the initial run with a shorter distance cutoff of 8 Å.
Surface conservation mapping. FASTA alignments of A. thaliana MPK6 and H. sapiens ERK1, ERK2, ERK5, p38α, p38β, p38γ and p38δ were generated using Qiagen Bioinformatics CLC Sequence Viewer v.8.0.0. To map these onto our MPK6 structure, the alignments were exported into UCSF Chimera v1.11 (ref. 60 ), developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco. The Chimera MSMS package 61 and POVRay v.3.6 were used to model solvent-excluded molecular surfaces and generate raytraced images.
Protein extraction and immunoblotting. Agroinfiltrated N. benthamiana leaves expressing the desired constructs along with p19 were harvested 2 d after infiltration and ground in liquid nitrogen. The proteins were extracted using the following extraction buffer: 100 mM Tris-HCl pH 8.0, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 10 mM sodium fluoride, 1 mM sodium orthovanadate, 1 mM EDTA, 1 mM PMSF and 1:100 protease inhibitor cocktail. The frozen ground tissue was then ground again in extraction buffer and the total extract centrifuged at 16,000g at 4 °C for 20 min. The supernatant was transferred to a new tube. The protein concentration was measured using the Bradford Reagent (Bio-Rad) and final protein concentration of each sample was adjusted to 20 μg per lane before loading onto an SDS-PAGE gel. The proteins were separated using SDS-PAGE (10% acrylamide gel) and transferred to a nitrocellulose transfer membrane (Immobilon, EMD Millipore) using a semi-dry transfer set-up. The samples were transferred at 120 mA for 2 h. The membranes were then blocked in 1× TBST buffer containing 5% non-fat dry milk powder, after which the membranes were incubated with primary antibodies (in 5% milk, 1× TBST) overnight. The membranes were washed three times using 1× TBST and then incubated with secondary antibodies (in 5% milk, 1× TBST) at room temperature for 2 h. The membranes were then washed three times using 1× TBST, after which the bands were detected using SuperSignal West Femto Maximum Sensitivity Substrate (1:1).
Recombinant protein expression and in vitro kinase assay. For in vitro protein expression, the constructs of pGEX-4T-1-SCRM, pGEX-4T-1-scrmD, pET-28a-MPK3, pET-28a-MPK6 and pET-28a-MKK5 DD were transformed into E. coli strain BL21. For each transformant, a single clone was selected and incubated in 3 ml LB liquid medium. The overnight-incubated E. coli suspensions were transferred to 300 ml LB medium and incubated at 37 °C for around 3 h until the OD 600 reached 0.4-0.6. The isopropyl β-d-1-thiogalactopyranoside (0.5 μM of final concentration) was added to the cultures and the strains were incubated at 25 °C for a further 5 h. SCRM and scrm-D proteins were purified using glutathione agarose resin, and MPK3, MPK6 and MKK5 DD proteins were purified using Ni-NTA agarose according to the manufacturer's protocol. For the in vitro kinase assay, two steps of reactions were conducted. First, MPK3 or MPK6 protein alone or together with MKK5 DD were incubated in 30 μl of reaction buffer: 25 mM TrisHCl (pH 7.5), 12 mM MgCl 2 , 1 mM DTT and 50 μM ATP. The mixtures were kept at room temperature for 30 min. In the second step, 5 μl solution from each of the first reactions was incubated with SCRM and scrm-D in 25 μL of reaction buffer: 25 mM Tris-HCl (pH 7.5), 12 mM MgCl 2 , 1 mM DTT, 50 μM ATP and 0.1 mCi [γ-32 P]ATP. The reactions were processed for 30 min at room temperature before being stopped by adding SDS loading buffer. Proteins were separated by SDS-PAGE using a 10% (w/v) acrylamide gel, and the phosphorylated proteins were visualized by autoradiography.
BLI.
The binding affinities of the SCRM KiDoK full-length peptide and the scrm-D KiDoK full-length peptide with GST-tagged MPK3 and MPK6 were measured using the Octet Red96 system (ForteBio, Pall Life Sciences) following the manufacturer's protocols. The optical probes coated with streptavidin were first loaded with 100 nM biotinylated peptide (ligand) before kinetic binding analyses. The experiment was performed in black 96-well plates maintained at 30 °C. Each well was loaded with 200 μl reaction volume for the experiment. The binding buffer used in these experiments contained 1× PBS supplemented with 0.1% BSA. The concentrations of the GST-MPK3 as the analyte in the binding buffer were 1,000 nM, 333.33 nM, 111.11 nM, 37.03 nM, 12.34 nM and 4.11 nM. The concentrations of the GST-MPK6 as the analyte in the binding buffer were 150 nM, 75 nM, 37.5 nM, 18.75 nM, 9.375 nM and 4.6875 nM. All preformed complexes remained stable as suggested by the constant signal during the washing step after loading. There was no binding of the analytes to the unloaded probes as shown by the control wells. Binding kinetics to all six concentrations of the analytes were measured simultaneously using default parameters on the instrument. The data were analysed using the Octet data analysis software. The association and dissociation curves were fit with the 1:1 homogeneous ligand model. The kobs (observed rate constant) values were used to calculate K d , with steady-state analysis of the direct binding. See Supplementary Fig. 8 for raw sensorogram data. See Supplementary Table 4 for the exact values for each experiment.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
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